Clinical evidence, reimbursement guidance, and practice development insights from the wound care frontline
We write about the things that actually matter to wound care practices — billing changes that affect your bottom line, clinical evidence you can act on, and practical strategies for building a wound care program that delivers results for patients and your practice alike.
Up to 17% of patients develop allergic contact dermatitis to Dermabond's cyanoacrylate adhesive. Discover how biologic alternatives like fish skin grafts and spider silk offer safer, clinically superior wound closure without the allergy risk.
Read ArticleA step-by-step guide to launching an advanced wound care program — from assessing your patient base and building a formulary to training your billing team and marketing to referral sources. Realistic revenue expectations included.
Read ArticleThe complete guide to billing under the new CMS framework — CPT application codes, Q-code product reporting, FDA/HCPCS alignment requirements, documentation checklists, and strategies for avoiding the most common denial triggers.
Read ArticleThe TIME/TIMERS framework applied to biologic graft preparation — debridement strategies, infection management, moisture balance, and a practical readiness checklist so you never waste product on an unprepared wound bed.
Read ArticleAn honest, evidence-based comparison of fish skin grafts against the full spectrum of skin substitutes — human-derived, synthetic, and xenograft. Includes detailed Odinn Trial results and meta-analysis data with clinical context.
Read ArticleCMS reclassified skin substitutes from biologics to "incident-to" supplies with a flat $127/cm² rate. Here's what changed, which products are affected, and a 6-step compliance checklist for your practice.
Read Article